Fibrodysplasia Ossificans Progressiva (FOP) Active Not Recruiting Phase 3 Trials for Palovarotene (DB05467)

Also known as: FOP / Fibrodysplasia Ossificans Progressiva / Myositis ossificans progressiva, unspecified site / Myositis ossificans progressiva / Progressive myositis ossificans / Progressive myositis ossificans (disorder)

IndicationStatusPhase
DBCOND0086420 (Fibrodysplasia Ossificans Progressiva (FOP))Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05027802A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies.Treatment